Omada Health posts transcript of Q2 2026 earnings call
OMDA•Full-year outlook
Omada Health raised full-year revenue guidance to USD 334 million to USD 340 million and lifted its Adjusted EBITDA outlook to USD 21 million to USD 27 million.
Q2 2026 earnings call highlights
Omada Health discussed Q2 2026 results on an earnings call attended by CEO Sean Duffy, President Wei-Li Shao, and CFO Steve Cook.
- Duffy set a CEO transition: Shao becomes CEO on Jan. 1, 2027, and Duffy moves to executive chair.
- Revenue was USD 88 million, up 43% year over year.
- GAAP gross margin was 73%.
- GAAP net income was USD 5 million.
- Adjusted EBITDA was USD 11 million.
Membership and revenue per member
- Total members were 1,100,000, up 45% year over year.
- Trailing-12-month revenue per member was USD 284, versus USD 279.
